| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 17 |
| 1 | FLUOROURACIL CREAM, 0.5% | 17 |
| 2 | PANITUMUMAB | 16 |
| 3 | OXALIPLATIN | 7 |
| 4 | FILGRASTIM | 5 |
| 5 | APIXABAN | 3 |
| 6 | BEVACIZUMAB | 3 |
| 7 | DEXAMETHASONE | 3 |
| 8 | DEXAMETHASONE 1.5 MG | 3 |
| 9 | PEGFILGRASTIM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEBENDAZOLE | 1 | 0.0013 |
| 1 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 2 | PANITUMUMAB | 16 | 0.0010 |
| 3 | NIZATIDINE | 1 | 0.0007 |
| 4 | LEVOLEUCOVORIN | 1 | 0.0003 |
| 5 | DIFLUPREDNATE | 1 | 0.0003 |
| 6 | PEGFILGRASTIM | 3 | 0.0003 |
| 7 | FLUOROURACIL CREAM, 0.5% | 17 | 0.0002 |
| 8 | FLUOROURACIL | 17 | 0.0002 |
| 9 | RIPRETINIB | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 16 | 0.0003 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 17 | 0.0001 |
| 3 | Leukocyte Growth Factor [EPC] | 5 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 5 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 2 | 0.0000 |
| 8 | Factor Xa Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Aminosalicylate [EPC] | 1 | 0.0000 |